File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Oral midazolam sedation in third molar surgery

TitleOral midazolam sedation in third molar surgery
Authors
Keywordsmidazolam
molar,, third
sedation
tooth, removal of
Issue Date1987
PublisherChurchill Livingstone. The Journal's web site is located at http://www.elsevier.com/locate/ijom
Citation
International Journal Of Oral And Maxillofacial Surgery, 1987, v. 16 n. 3, p. 333-337 How to Cite?
AbstractA double-blind randomised study was designed to assess the value of oral midazolam in patients undergoing minor oral surgery. 30 young healthy Hong Kong Chinese with bilateral symmetrical impaction of lower third molars to be surgically removed in 2 visits, were included in the study. Randomly selected, a powdered midazolam tablet or placebo was given on the 1st visit and the alternative on the 2nd visit. 45 min were given for the drug to act. Surgical removal of the teeth was carried out by a single operator, randomly, one side being done at one visit. The majority who had midazolam were relaxed during the operation. Nearly 75% had partial to complete amnesia. Midazolam sedation lasted about 45 min, produced good operating conditions and stable vital signs with adequate verbal response. The main adverse effects were drowsiness and dizziness on the same day. The majority had never heard of oral sedation being available to supplement local anaesthesia. The majority preferred midazolam to placebo and preferred to have local anaesthesia supplemented with oral sedation for minor oral surgery in the future.
Persistent Identifierhttp://hdl.handle.net/10722/153622
ISSN
2023 Impact Factor: 2.2
2023 SCImago Journal Rankings: 0.875
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorRodrigo, MRCen_US
dc.contributor.authorCheung, LKen_US
dc.date.accessioned2012-08-08T08:20:42Z-
dc.date.available2012-08-08T08:20:42Z-
dc.date.issued1987en_US
dc.identifier.citationInternational Journal Of Oral And Maxillofacial Surgery, 1987, v. 16 n. 3, p. 333-337en_US
dc.identifier.issn0901-5027en_US
dc.identifier.urihttp://hdl.handle.net/10722/153622-
dc.description.abstractA double-blind randomised study was designed to assess the value of oral midazolam in patients undergoing minor oral surgery. 30 young healthy Hong Kong Chinese with bilateral symmetrical impaction of lower third molars to be surgically removed in 2 visits, were included in the study. Randomly selected, a powdered midazolam tablet or placebo was given on the 1st visit and the alternative on the 2nd visit. 45 min were given for the drug to act. Surgical removal of the teeth was carried out by a single operator, randomly, one side being done at one visit. The majority who had midazolam were relaxed during the operation. Nearly 75% had partial to complete amnesia. Midazolam sedation lasted about 45 min, produced good operating conditions and stable vital signs with adequate verbal response. The main adverse effects were drowsiness and dizziness on the same day. The majority had never heard of oral sedation being available to supplement local anaesthesia. The majority preferred midazolam to placebo and preferred to have local anaesthesia supplemented with oral sedation for minor oral surgery in the future.en_US
dc.languageengen_US
dc.publisherChurchill Livingstone. The Journal's web site is located at http://www.elsevier.com/locate/ijomen_US
dc.relation.ispartofInternational Journal of Oral and Maxillofacial Surgeryen_US
dc.subjectmidazolam-
dc.subjectmolar,, third-
dc.subjectsedation-
dc.subjecttooth, removal of-
dc.subject.meshAdministration, Oralen_US
dc.subject.meshAdolescenten_US
dc.subject.meshAdulten_US
dc.subject.meshAnesthesia, Dentalen_US
dc.subject.meshDizziness - Chemically Induceden_US
dc.subject.meshDouble-Blind Methoden_US
dc.subject.meshFemaleen_US
dc.subject.meshHumansen_US
dc.subject.meshMaleen_US
dc.subject.meshMidazolam - Administration & Dosage - Adverse Effectsen_US
dc.subject.meshMolar, Third - Surgeryen_US
dc.subject.meshPreanesthetic Medicationen_US
dc.subject.meshRandom Allocationen_US
dc.subject.meshSleep Stagesen_US
dc.subject.meshTooth, Impacted - Surgeryen_US
dc.titleOral midazolam sedation in third molar surgeryen_US
dc.typeArticleen_US
dc.description.naturelink_to_subscribed_fulltexten_US
dc.identifier.doi10.1016/S0901-5027(87)80155-8-
dc.identifier.pmid3112263-
dc.identifier.scopuseid_2-s2.0-0023571515en_US
dc.identifier.volume16en_US
dc.identifier.issue3en_US
dc.identifier.spage333en_US
dc.identifier.epage337en_US
dc.identifier.isiWOS:A1987J098100012-
dc.publisher.placeUnited Kingdomen_US
dc.identifier.issnl0901-5027-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats